logo
[breadcrumb_custom]

Tag: TVTX Shares

THMO
News

Anchoring Your Portfolio: Is TVTX Stock a Safe Harbor?

The stock market performance of Travere Therapeutics Inc has been fairly unsteady. Over the last year, the company’s stock hit its highest at $22.75 on 05/01/23, while the lowest price during the same time frame was $5.25, recorded on 11/10/23. 52-week price history of TVTX Stock A stock’s 52-week high and low prices can reveal a great deal about its present condition and potential future performance. Travere Therapeutics Inc’s current trading price is -76.04% away from its 52-week high, while its distance from the 52-week low is 3.81%. The stock’s price range during this period has fluctuated between $5.25 and

News

Travere Therapeutics Inc (TVTX) Stock: A Year of Stock Market Ups and Downs

A stock’s 52-week high and low prices can offer a wealth of information about its current standing and prospective future performance. Travere Therapeutics Inc’s current trading price is -70.68% away from its 52-week high, while its distance from the 52-week low is 27.05%. The stock’s price range for this time frame has been between $5.25 and $22.75. The trading volume of the company’s shares in the Healthcare reached around 2.54 million for the day, which was evidently higher than the average daily volume of 1.18 million over the last three months. In terms of market performance, Travere Therapeutics Inc had

Stock

Travere Therapeutics Inc (TVTX) Stock: The Story of a 52-Week Stock Range

The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Travere Therapeutics Inc’s current trading price is -67.51% away from its 52-week high, while its distance from the 52-week low is 43.43%. The stock’s price range for this period has been between $5.25 and $23.17 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 1.01 million for the day, a number notably lower than the average daily volume of 1.29 million over the last three months. Travere Therapeutics Inc ‘s stock market performance